Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
. Responsible for routine isolation, interpretation, identification, and/or antibiotic susceptibility testing of all types of specimens for bacteria, mycobacteria, fungi, and parasites. Interpret smears
-
dimethylsulfide (DMS). This is because coastal sediments typically have high salinity, and thus high sulfate levels. In high-sulfate ecosystems, sulfate-reducing bacteria (SRB) may outcompete methane-producers
-
airborne pathogens such as viruses, bacteria, and fungal spores. Current approaches are slow and labor-intensive, often relying on culture-based analysis that requires several days. This project aims
-
be biochemical assays, microscopy, flow cytometry, qPCR and RNAseq approaches. This project will generate an understanding of how interactions between bacteria and their host cells regulate signalling
-
health and disease, with particular interest in identifying and investigating small molecule metabolites and natural products, made or modified by commensal bacteria, that modulate human physiology. We
-
of the following: Managing budgets or financial resources Lab management Preparation of microbiological media and reagents, sterile technique, cultivation of bacteria Chemical and molecular methods such as gel
-
expert to strengthen the genetic engineering pipeline of Cutibacterium acnes within the EU-funded SkinEngineering project. SkinEngineering aims to advance our engineered-skin-bacteria technology, bringing
-
, assisting with the isolation and cultivation of gut bacteria associated with heat adaptation, identifying genetic and developmental variation associated with heat adaptation, experimental manipulations of gut
-
Centers; and the R01 – Role of Bacteria in Colitis-Associated Colon Cancer, all from the NIH. The program trains 13 Gastroenterology fellows and 1-2 Advanced Endoscopy fellows per year, and education of
-
the impact of the ERA Chair IBMC-i3S in Immunology. 3. Work plan: The alarming increase in multidrug-resistant bacteria, coupled with stagnation in antibiotic development, demands new therapeutic approaches